MENU
IGC Pharma (IGC) Ownership - Who owns IGC Pharma?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
10224 Falls Road
Phone
+1 301 983-0998
Employees
61
Web
https://www.igcinc.us
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
26.7M
P/E Ratio
N/A
Total Cash
1.82M
Projected Growth
N/A
Total Debt
338K
Revenue
1.06M
Risk (Beta)
0.25
Dividend Yield
N/A
Total Cash/Share
0.02
Total Debt/Equity
15.73
Revenue/Share
0.02 USD as % of share price
Fundamentals
IGC
Capitalization
26.7M
P/E Ratio
N/A
Risk (Beta)
0.25
Dividend Yield
N/A
Total Cash
1.82M
Total Cash/Share
0.02
Total Debt
338K
Total Debt/Equity
15.73
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
1.06M
ROE
N/A
Book Value
7.88M
P/B Ratio
3.39
Cash Flow
N/A
Earnings
-0.21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
127M
Current Ratio
1.77
Current Revenue Per Employee
4059.70
Dividends Per Share - Security
N/A
EBITDA
-9.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
59.93
Revenue To Assets
-101.29
Shares Held By Institutions
1.21M
Shares Outstanding - Current
75.6M
Total Liabilities
2.71M
Total Volume MTD
N/A
Value
N/A
Gain YTD
23.242
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in focuses on developing and commercializing a portfolio of cannabinoid based biopharmaceutical therapies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
10224 Falls Road
Phone
+1 301 983-0998
Employees
61
Web
https://www.igcinc.us